Dusty Linn, PharmD, MBA's Avatar

Dusty Linn, PharmD, MBA

@dustylinn.bsky.social

Pharmacist | Critical Care | BCPS | BCCCP Neuromuscular Monitoring | Sugammadex | Medical Technology

19 Followers  |  22 Following  |  3 Posts  |  Joined: 18.11.2024  |  1.2988

Latest posts by dustylinn.bsky.social on Bluesky

Preview
Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents - PubMed By applying key strategies to prevent AWP, pharmacists can help make AWP a never event in both procedural and continuous use of NMBAs.

I’ll assume that @meganarech.bsky.social discussed AWP!

pubmed.ncbi.nlm.nih.gov/40119713/

21.10.2025 19:21 — 👍 1    🔁 0    💬 0    📌 0
Preview
Residual neuromuscular block in the postanaesthesia care unit: a single-centre prospective observational study and systematic review - PubMed The incidence of residual neuromuscular block in the PACU was 2.2%. This suggests significant improvement in the prevention of residual neuromuscular block and stresses the importance of rigorous neur...

Things we know that continue to be proven:

Neuromuscular monitoring reduces the incidence of residual neuromuscular blockade after surgery. Sugammadex isn't a perfect reversal agent.

pubmed.ncbi.nlm.nih.gov/39443187/

27.01.2025 17:38 — 👍 0    🔁 0    💬 0    📌 0

ACCP Critical Care PRN members, please complete the Spring recognition survey by February 17, 2025.

bit.ly/3WcL6JN

On behalf of the PRN recognition committee, we look forward to highlighting your success!
@vccpharmd.bsky.social

14.01.2025 18:34 — 👍 3    🔁 1    💬 0    📌 0

@dustylinn is following 19 prominent accounts